Article Information
PubMed
Published By
History
- Received December 1, 2006
- Revision received May 3, 2007
- Accepted May 4, 2007
- First published June 13, 2007.
- Version of record published June 13, 2007.
Copyright & Usage
Copyright © 2007 Society for Neuroscience 0270-6474/07/276400-12$15.00/0
Author Information
- Michael McEvoy*,
- Guan Cao*,
- Paula Montero Llopis,
- Mitchell Kundel,
- Kendrick Jones,
- Catherine Hofler,
- Chan Shin, and
- David G. Wells
- Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06520
- Correspondence should be addressed to David G. Wells, 219 Prospect Street, KBT 226, Box 208103, Yale University, New Haven, CT 06520-8103. david.wells{at}yale.edu
Author contributions
-
↵*M.M. and G.C. contributed equally to this work.
Disclosures
- Received December 1, 2006.
- Revision received May 3, 2007.
- Accepted May 4, 2007.
-
This work was supported by National Institute of Mental Health Grant RO1 MH66274 (D.G.W.) and The Ellison Medical Foundation (D.G.W.). We thank Drs. J. Oberdick (The Ohio State University, Columbus, OH) and W. Zhong (Yale University, New Haven, CT) for the pL7ΔAUG construct, Dr. A. Hall (Memorial Sloan-Kettering Cancer Center, New York, NY) for the IRSp53 antibody, Dr. T. Kapoor (Rockefeller University, New York, NY) for the Aurora kinase inhibitor Hesperadin, and Dr. P. Rao, N. Papastathis, and G. Thomas for excellent technical assistance.
- Correspondence should be addressed to David G. Wells, 219 Prospect Street, KBT 226, Box 208103, Yale University, New Haven, CT 06520-8103. david.wells{at}yale.edu
Online Impact